Switch theme
Sign up to access all valuation multiples
Shimadzu Corp manufactures scientific instruments. The firm operates in four segments: analytical and measuring instruments, medical systems, aircraft equipment, and industrial machinery. The analytical and measuring instruments segment produces chromatograph mass spectrometers, surface analyzers, and environmental measurement instruments for the pharmaceutical, chemical, and life science industries. The medical systems segment provides diagnostic imaging equipment for hospitals and medical offices. The aircraft equipment segment sells air-conditioning systems, flight control systems, and displays. The industrial machinery segment sells products to major manufacturing equipment makers, including hydraulic equipment. The majority of Shimadzu's revenue is generated in Japan.
1875
14.1K+
LTM Revenue $3.7B
LTM EBITDA $631M
$6.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Shimadzu has a last 12-month revenue (LTM) of $3.7B and a last 12-month EBITDA of $631M.
In the most recent fiscal year, Shimadzu achieved revenue of $3.5B and an EBITDA of $658M.
Shimadzu expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Shimadzu valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | XXX | $3.5B | XXX | XXX | XXX |
| Gross Profit | $1.7B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Margin | 47% | XXX | 43% | XXX | XXX | XXX |
| EBITDA | $631M | XXX | $658M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $495M | XXX | $499M | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $371M | XXX | $391M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Shimadzu's stock price is JPY 3493 (or $24).
Shimadzu has current market cap of JPY 1.01T (or $6.9B), and EV of JPY 877B (or $6.0B).
See Shimadzu trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6.0B | $6.9B | XXX | XXX | XXX | XXX | $1.27 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Shimadzu has market cap of $6.9B and EV of $6.0B.
Shimadzu's trades at 1.7x EV/Revenue multiple, and 9.3x EV/EBITDA.
Equity research analysts estimate Shimadzu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Shimadzu has a P/E ratio of 18.7x.
See valuation multiples for Shimadzu and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6.9B | XXX | $6.9B | XXX | XXX | XXX |
| EV (current) | $6.0B | XXX | $6.0B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 9.5x | XXX | 9.3x | XXX | XXX | XXX |
| EV/EBIT | 12.2x | XXX | 12.3x | XXX | XXX | XXX |
| EV/Gross Profit | 3.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.7x | XXX | 18.1x | XXX | XXX | XXX |
| EV/FCF | 23.7x | XXX | 46.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialShimadzu's last 12 month revenue growth is 2%
Shimadzu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Shimadzu's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shimadzu's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Shimadzu and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 21% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 29% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shimadzu acquired XXX companies to date.
Last acquisition by Shimadzu was XXXXXXXX, XXXXX XXXXX XXXXXX . Shimadzu acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Shimadzu founded? | Shimadzu was founded in 1875. |
| Where is Shimadzu headquartered? | Shimadzu is headquartered in Japan. |
| How many employees does Shimadzu have? | As of today, Shimadzu has 14.1K+ employees. |
| Who is the CEO of Shimadzu? | Shimadzu's CEO is Mr. Yasunori Yamamoto. |
| Is Shimadzu publicy listed? | Yes, Shimadzu is a public company listed on TKS. |
| What is the stock symbol of Shimadzu? | Shimadzu trades under 7701 ticker. |
| When did Shimadzu go public? | Shimadzu went public in 1949. |
| Who are competitors of Shimadzu? | Similar companies to Shimadzu include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Shimadzu? | Shimadzu's current market cap is $6.9B |
| What is the current revenue of Shimadzu? | Shimadzu's last 12 months revenue is $3.7B. |
| What is the current revenue growth of Shimadzu? | Shimadzu revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Shimadzu? | Current revenue multiple of Shimadzu is 1.6x. |
| Is Shimadzu profitable? | Yes, Shimadzu is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Shimadzu? | Shimadzu's last 12 months EBITDA is $631M. |
| What is Shimadzu's EBITDA margin? | Shimadzu's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Shimadzu? | Current EBITDA multiple of Shimadzu is 9.5x. |
| What is the current FCF of Shimadzu? | Shimadzu's last 12 months FCF is $254M. |
| What is Shimadzu's FCF margin? | Shimadzu's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Shimadzu? | Current FCF multiple of Shimadzu is 23.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
